SGP
SGP
US85220G1094
SpyGlass Pharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
41.449.000 27.064.000
53.2%
Operating Income -41.449.000 -27.064.000
53.2%
Pretax Income -39.869.000 -29.164.000
36.7%
Net Income Common Stockholders -39.869.000 -29.164.000
36.7%
-- --
--
-- --
--
ende